# BCAAs in Concussion 3.0

> **NCT07670195** · PHASE2 · RECRUITING · sponsor: **Akiva Cohen** · enrollment: 150 (estimated)

## Conditions studied

- Concussion (Diagnosis)
- MTBI - Mild Traumatic Brain Injury
- Concussion, Brain
- Concussion

## Interventions

- **DRUG:** BCAA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07670195
- **Lead sponsor:** Akiva Cohen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-05
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670195, "BCAAs in Concussion 3.0". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*